Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Tetra is moving up on the Dronabinol Approval list

<< Previous

Bullboard Posts

Next >>

Comment by Normandton Jun 17, 2022 9:23am

89 Views

Post# 34763981

RE:RE:RE:RE:RE:RE:RE:RE:RE:Tetra is moving up on the Dronabinol Approval list

it's very strange. I did the same sorting several times and after 4 or 5 tries, dronabinol just changed to 2nd position, like you said. The first one is "Erwinia L-asparaginase".

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"